<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
  <meta charset="utf-8" />
  <meta name="generator" content="pandoc" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
  <meta name="author" content="hbaolong@vip.qq.com" />
  <title>癌症传EN:“A spider’s web”</title>
  <style>
    html {
      color: #1a1a1a;
      background-color: #fdfdfd;
    }
    body {
      margin: 0 auto;
      max-width: 36em;
      padding-left: 50px;
      padding-right: 50px;
      padding-top: 50px;
      padding-bottom: 50px;
      hyphens: auto;
      overflow-wrap: break-word;
      text-rendering: optimizeLegibility;
      font-kerning: normal;
    }
    @media (max-width: 600px) {
      body {
        font-size: 0.9em;
        padding: 12px;
      }
      h1 {
        font-size: 1.8em;
      }
    }
    @media print {
      html {
        background-color: white;
      }
      body {
        background-color: transparent;
        color: black;
        font-size: 12pt;
      }
      p, h2, h3 {
        orphans: 3;
        widows: 3;
      }
      h2, h3, h4 {
        page-break-after: avoid;
      }
    }
    p {
      margin: 1em 0;
    }
    a {
      color: #1a1a1a;
    }
    a:visited {
      color: #1a1a1a;
    }
    img {
      max-width: 100%;
    }
    svg {
      height: auto;
      max-width: 100%;
    }
    h1, h2, h3, h4, h5, h6 {
      margin-top: 1.4em;
    }
    h5, h6 {
      font-size: 1em;
      font-style: italic;
    }
    h6 {
      font-weight: normal;
    }
    ol, ul {
      padding-left: 1.7em;
      margin-top: 1em;
    }
    li > ol, li > ul {
      margin-top: 0;
    }
    blockquote {
      margin: 1em 0 1em 1.7em;
      padding-left: 1em;
      border-left: 2px solid #e6e6e6;
      color: #606060;
    }
    code {
      font-family: Menlo, Monaco, Consolas, 'Lucida Console', monospace;
      font-size: 85%;
      margin: 0;
      hyphens: manual;
    }
    pre {
      margin: 1em 0;
      overflow: auto;
    }
    pre code {
      padding: 0;
      overflow: visible;
      overflow-wrap: normal;
    }
    .sourceCode {
     background-color: transparent;
     overflow: visible;
    }
    hr {
      background-color: #1a1a1a;
      border: none;
      height: 1px;
      margin: 1em 0;
    }
    table {
      margin: 1em 0;
      border-collapse: collapse;
      width: 100%;
      overflow-x: auto;
      display: block;
      font-variant-numeric: lining-nums tabular-nums;
    }
    table caption {
      margin-bottom: 0.75em;
    }
    tbody {
      margin-top: 0.5em;
      border-top: 1px solid #1a1a1a;
      border-bottom: 1px solid #1a1a1a;
    }
    th {
      border-top: 1px solid #1a1a1a;
      padding: 0.25em 0.5em 0.25em 0.5em;
    }
    td {
      padding: 0.125em 0.5em 0.25em 0.5em;
    }
    header {
      margin-bottom: 4em;
      text-align: center;
    }
    #TOC li {
      list-style: none;
    }
    #TOC ul {
      padding-left: 1.3em;
    }
    #TOC > ul {
      padding-left: 0;
    }
    #TOC a:not(:hover) {
      text-decoration: none;
    }
    code{white-space: pre-wrap;}
    span.smallcaps{font-variant: small-caps;}
    div.columns{display: flex; gap: min(4vw, 1.5em);}
    div.column{flex: auto; overflow-x: auto;}
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
    /* The extra [class] is a hack that increases specificity enough to
       override a similar rule in reveal.js */
    ul.task-list[class]{list-style: none;}
    ul.task-list li input[type="checkbox"] {
      font-size: inherit;
      width: 0.8em;
      margin: 0 0.8em 0.2em -1.6em;
      vertical-align: middle;
    }
    .display.math{display: block; text-align: center; margin: 0.5rem auto;}
  </style>
</head>
<body>
<header id="title-block-header">
<h1 class="title">癌症传EN:“A spider’s web”</h1>
<p class="author">hbaolong@vip.qq.com</p>
</header>
<center>
<a href="/3place/azzen">返回首页</a> <a
href="/3place/azzen/mingju.html">本书名句</a> <a
href="/3place/azzen/memo.html">本书注解</a> <a
href="/3place/azzen/index_rich.html">丰富目录</a> <a
href="/3place/azzen/index_readcal.html">同读日历</a> <a
href="/3place/azzen/index_timeline.html">时间线</a> <a
href="/3place/azzen/index_books.html">引用书籍</a> <a
href="/3place/azzen/index_words.html">使用字频</a>
<div id="wx_pic" style="margin:0 auto;display:none;">
<img src='/img/logo.png'/>
</div>
</center>
<h4 id="a-spiders-web">“A spider’s web”</h4>
<p>286 It is to earlier diagnosis that we must look: J. P.
Lockhart-Mummery, “Two Hundred Cases of Cancer of the Rectum Treated by
Perineal Excision,” British Journal of Surgery 14 (1926–27): 110–24.</p>
<p>286 The greatest need we have today: Sidney Farber, letter to Etta
Rosensohn, November 1962.</p>
<p>286 Lady, have you been “Paptized”?: “Lady, Have You Been
‘Paptized’?” New York Amsterdam News, April 13, 1957.</p>
<p>286 George Papanicolaou: For an overview, see George A. Vilos, “After
Office Hours: The History of the Papanicolaou Smear and the Odyssey of
George and Andromache Papanicolaou,” Obstetrics and Gynecology 91, no. 3
(1998): 479–83; S. Zachariadou-Veneti, “A Tribute to George Papanicolaou
(1883–1962),” Cytopathology 11, no. 3 (2000): 152–57.</p>
<p>287 By the late 1920s: Zachariadou-Veneti, “Tribute to George
Papanicolaou.”</p>
<p>287 As one gynecologist archly remarked: Edgar Allen, “Abstract of
Discussion on Ovarian Follicle Hormone,” Journal of the American Medical
Association 85 (1925): 405.</p>
<p>287 Papanicolaou thus began to venture: George N. Papanicolaou, “The
Cancer-Diagnostic Potential of Uterine Exfoliative Cytology,” CA: A
Cancer Journal for Clinicians 7 (1957): 124–35.</p>
<p>288 “aberrant and bizarre forms”: Ibid.</p>
<p>288 Papanicolaou published his method: G. N. Papanicolaou, “New
Cancer Diagnosis,” Proceedings of the Third Race Betterment Conference
(1928): 528.</p>
<p>288 “I think this work will be carried”: Ibid.</p>
<p>288 Between 1928 and 1950: George A. Vilos, “After Office Hours,”
Obstetrics and Gynecology 91 (March 1998): 3.</p>
<p>288 A Japanese fish and bird painter: George N. Papanicolaou, “The
Cell Smear Method of Diagnosing Cancer,” American Journal of Public
Health and the Nation’s Health 38, no. 2 (1948): 202–5.</p>
<p>289 At a Christmas party in the winter of 1950: Irena Koprowska, A
Woman Wanders through Life and Science (Albany: State University of New
York Press, 1997), 167–68.</p>
<p>289 “It was a revelation”: Ibid.</p>
<p>289 In 1952, Papanicolaou convinced the National Cancer Institute:
Cyrus C. Erickson, “Exfoliative Cytology in Mass Screening for Uterine
Cancer: Memphis and Shelby County, Tennessee,” CA: A Cancer Journal for
Clinicians 5 (1955): 63–64.</p>
<p>289 In the initial cohort of about 150,000: Harold Speert, “Memorable
Medical Mentors: VI. Thomas S. Cullen (1868–1953),” Obstetrical and
Gynecological Survey 59, no. 8 (2004): 557–63.</p>
<p>289 557 women were found to have preinvasive cancers: Ibid.</p>
<p>290 In 1913, a Berlin surgeon named Albert Salomon: D. J. Dronkers et
al., eds., The Practice of Mammography: Pathology, Technique,
Interpretation, Adjunct Modalities (New York: Thieme, 2001), 256.</p>
<p>291 “trabeculae as thin as a spider’s web”: H. J. Burhenne, J. E.
Youker, and R. H. Gold, eds., Mammography (symposium given on August 24,
1968, at the University of California School of Medicine, San Francisco)
(New York: S. Karger, 1969), 109.</p>
<p>294 In the winter of 1963, three men set out: Sam Shapiro, Philip
Strax, and Louis Venet, “Evaluation of Periodic Breast Cancer Screening
with Mammography: Methodology and Early Observations,” Journal of the
American Medical Association 195, no. 9 (1966): 731–38.</p>
<p>294 By the mid-1950s, a triad of forces: Thomas A. Hirschl and Tim B.
Heaton, eds., New York State in the 21st Century (Santa Barbara, CA:
Greenwood Publishing Group, 1999), 144.</p>
<p>294 By the early 1960s, the plan had enrolled: See, for instance,
Philip Strax, “Screening for breast cancer,” Clinical Obstetrics and
Gynecology 20, no. 4 (1977): 781–802.</p>
<p>295 Strax and Venet eventually outfitted a mobile van: Philip Strax,
“Female Cancer Detection Mobile Unit,” Preventive Medicine 1, no. 3
(1972): 422–25.</p>
<p>295 “Interview . . . 5 stations X 12 women”: Abraham Schiff quoted in
Philip Strax, Control of Breast Cancer through Mass Screening
(Philadelphia: Mosby, 1979), 148.</p>
<p>296 In 1971, eight years after the study: S. Shapiro et al.,
“Proceedings: Changes in 5-Year Breast Cancer Mortality in a Breast
Cancer Screening Program,” Proceedings of the National Cancer Conference
7 (1972): 663–78.</p>
<p>296 “The radiologist,” he wrote: Philip Strax, “Radiologist’s Role in
Screening Mammography,” unpublished document quoted in Barron H. Lerner,
“‘To See Today with the Eyes of Tomorrow’: A History of Screening
Mammography,” Canadian Bulletin of Medical History 20, no. 2 (2003):
299–321.</p>
<p>296 “Within 5 years, mammography has moved”: G. Melvin Stevens and
John F. Weigen, “Mammography Survey for Breast Cancer Detection. A
2-Year Study of 1,223 Clinically Negative Asymptomatic Women over 40,”
Cancer 19, no. 1 (2006): 51–59.</p>
<p>296 “The time has come”: Arthur I. Holleb, “Toward Better Control of
Breast Cancer,” American Cancer Society press release, October 4, 1971
(New York: ACS Media Division), Folder: Breast Cancer Facts, quoted in
Lerner, “‘To See Today with the Eyes of Tomorrow.’”</p>
<p>296 the Breast Cancer Detection and Demonstration Project: Myles P.
Cunningham, “The Breast Cancer Detection Demonstration Project 25 Years
Later,” CA: A Cancer Journal for Clinicians 47, no. 3 (1997):
131–33.</p>
<p>298 Between 1976 and 1992, enormous parallel trials: See below for
particular studies. Also see Madelon Finkel, ed., Understanding the
Mammography Controversy (Westport, CT: Praeger, 2005), 101–5.</p>
<p>298 In Canada, meanwhile, researchers lurched: A. B. Miller, G. R.
Howe, and C. Wall, “The National Study of Breast Cancer Screening
Protocol for a Canadian Randomized Controlled Trial of Screening for
Breast Cancer in Women,” Clinical Investigative Medicine 4, nos. 3–4
(1981): 227–58.</p>
<p>298 Edinburgh was a disaster: A. Huggins et al., “Edinburgh Trial of
Screening for Breast Cancer: Mortality at Seven Years,” Lancet 335, no.
8684 (1990): 241–46; Denise Donovan et al., “Edinburgh Trial of
Screening for Breast Cancer,” Lancet 335, no. 8695 (1990): 968–69.</p>
<p>298 The Canadian trial, meanwhile: Miller, Howe, and Wall, “National
Study of Breast Cancer Screening Protocol.”</p>
<p>298 For a critical evaluation of the CNBSS, HIP, and Swedish studies,
see David Freedman et al., “On the Efficacy of Screening for Breast
Cancer,” International Journal of Epidemiology 33, no. 1 (2004):
43–5.</p>
<p>298 Randomization problems in the Canadian National Breast Screening
Study: Curtis J. Mettlin and Charles R. Smart, “The Canadian National
Breast Screening Study: An Appraisal and Implications for Early
Detection Policy,” Cancer 72, no. S4 (1993): 1461–65; John C. Bailar III
and Brian MacMahon, “Randomization in the Canadian National Breast
Screening Study: A Review for Evidence of Subversion,” Canadian Medical
Association Journal 156, no. 2 (1997): 193–99.</p>
<p>299 “Suspicion, like beauty”: Cornelia Baines, Canadian Medical
Association Journal 157 (August 1, 1997): 249.</p>
<p>299 “One lesson is clear”: Norman F. Boyd, “The Review of
Randomization in the Canadian National Breast Screening Study: Is the
Debate Over?” Canadian Medical Association Journal 156, no. 2 (1997):
207–9.</p>
<p>300 Migration into and out of the city: See, for instance,
Scandinavian Journal of Gastroenterology 30 (1995): 33–43.</p>
<p>300 In 1976, forty-two thousand women enrolled: Ingvar Andersson et
al., “Mammographic Screening and Mortality from Breast Cancer: The Malmö
Mammographic Screening Trial,” British Medical Journal 297, no. 6654
(1988): 943–48.</p>
<p>300 “There was only one”: Ingvar Andersson, interview with author,
March 2010.</p>
<p>300 In 1988, at the end of its twelfth year: Andersson et al.,
“Mammographic Screening and Mortality.” Also Andersson, interview with
author.</p>
<p>300 When the groups were analyzed by age: Ibid.</p>
<p>301 In 2002, twenty-six years after the launch of the original:
Lennarth Nystöm et al., “Long-Term Effects of Mammography Screening:
Updated Overview of the Swedish Randomised Trials,” Lancet 359, no. 9310
(2002): 909–19.</p>
<p>301 Its effects, as the statistician Donald Berry describes it:
Donald Berry, interview with author, November 2009.</p>
<p>301 Berry wrote, “Screening is a lottery”: “Mammograms Before 50 a
Waste of Time,” Science a Go Go, October 12, 1998,
http://www.scienceagogo.com/news/ 19980912094305data_trunc_sys.shtml
(accessed December 29, 2009).</p>
<p>302 “This is a textbook example”: Malcolm Gladwell, “The Picture
Problem: Mammography, Air Power, and the Limits of Looking,” New Yorker,
December 13, 2004.</p>
<p>303 “All photographs are accurate”: Richard Avedon, An Autobiography
(New York: Random House, 1993); Richard Avedon, Evidence, 1944–1994 (New
York: Random House, 1994).</p>
<p>304 “As the decade ended,” Bruce Chabner: Bruce Chabner, interview
with author, August 2009.</p>
<h6 id="阅读日期-2026年01月28日-2026年01月28日-共-1-天">阅读日期：
2026年01月28日-2026年01月28日 共： 1 天</h6>
<script src="https://giscus.app/client.js"
        data-repo="hbaolong/hbaolong.github.io"
        data-repo-id="R_kgDOLetDQg"
        data-category="General"
        data-category-id="DIC_kwDOLetDQs4CfLEl"
        data-mapping="url"
        data-strict="0"
        data-reactions-enabled="1"
        data-emit-metadata="1"
        data-input-position="top"
        data-theme="preferred_color_scheme"
        data-lang="zh-CN"
        crossorigin="anonymous"
        async>
</script>
</body>
</html>
